Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level
- First Posted Date
- 2017-07-07
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT03211403
- Locations
- 🇦🇺
Atridia Pty Limited, Sydney, New South Wales, Australia
A Trial of HTI-1090 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2017-07-06
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT03208959
- Locations
- 🇦🇺
Icon Cancer Care Centre, South Brisbane, New South Wales, Australia
A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT03133247
- Locations
- 🇦🇺
Linear Clinical Research, Perth, West Australia, Australia
A Single Dose Study of SHR4640 in Healthy Male Volunteers
- First Posted Date
- 2017-01-10
- Last Posted Date
- 2018-07-03
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03015948
- Locations
- 🇦🇺
Atridia Pty Limited, Sydney, New South Wales, Australia
A Study of SHR-1314 in Healthy Subjects
- First Posted Date
- 2016-10-17
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT02934412
- Locations
- 🇦🇺
Atridia Pty Limited, Sydney, New South Wales, Australia
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02759666
- Locations
- 🇦🇺
Linear, Melbourne, Australia
🇦🇺Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺Border Medical Oncology, Albury, New South Wales, Australia
A Phase I Trial of HS-10241 in Solid Tumors
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 7
- Registration Number
- NCT02759640
- Locations
- 🇦🇺
Liverpool, Liverpool, New South Wales, Australia
🇦🇺Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer
- Conditions
- NeoplasmProstate Cancer
- Interventions
- Drug: SHR3680; SHR3162
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 33
- Registration Number
- NCT02747342
- Locations
- 🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia
🇦🇺Border Medical Oncology, Albury, New South Wales, Australia
🇦🇺St George Hospital, Kogarah, New South Wales, Australia
A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients
- Conditions
- Solid Tumors and Hematologic Malignancy
- Interventions
- Biological: INCSHR01210 injection
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 49
- Registration Number
- NCT02492789
- Locations
- 🇦🇺
Austin Hospital/Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
🇦🇺Linear Clinical Research Limited, Nedlands, Australia
🇦🇺Blacktown Hospital, Blacktown, Australia